UniProt ID | FOXP3_HUMAN | |
---|---|---|
UniProt AC | Q9BZS1 | |
Protein Name | Forkhead box protein P3 | |
Gene Name | FOXP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 431 | |
Subcellular Localization | Nucleus . Cytoplasm . Predominantly expressed in the cytoplasm in activated conventional T-cells whereas predominantly expressed in the nucleus in regulatory T-cells (Treg). The 41 kDa form derived by proteolytic processing is found exclusively in th | |
Protein Description | Transcriptional regulator which is crucial for the development and inhibitory function of regulatory T-cells (Treg). Plays an essential role in maintaining homeostasis of the immune system by allowing the acquisition of full suppressive function and stability of the Treg lineage, and by directly modulating the expansion and function of conventional T-cells. Can act either as a transcriptional repressor or a transcriptional activator depending on its interactions with other transcription factors, histone acetylases and deacetylases. The suppressive activity of Treg involves the coordinate activation of many genes, including CTLA4 and TNFRSF18 by FOXP3 along with repression of genes encoding cytokines such as interleukin-2 (IL2) and interferon-gamma (IFNG). Inhibits cytokine production and T-cell effector function by repressing the activity of two key transcription factors, RELA and NFATC2. [PubMed: 15790681 Mediates transcriptional repression of IL2 via its association with histone acetylase KAT5 and histone deacetylase HDAC7] | |
Protein Sequence | MPNPRPGKPSAPSLALGPSPGASPSWRAAPKASDLLGARGPGGTFQGRDLRGGAHASSSSLNPMPPSQLQLPTLPLVMVAPSGARLGPLPHLQALLQDRPHFMHQLSTVDAHARTPVLQVHPLESPAMISLTPPTTATGVFSLKARPGLPPGINVASLEWVSREPALLCTFPNPSAPRKDSTLSAVPQSSYPLLANGVCKWPGCEKVFEEPEDFLKHCQADHLLDEKGRAQCLLQREMVQSLEQQLVLEKEKLSAMQAHLAGKMALTKASSVASSDKGSCCIVAAGSQGPVVPAWSGPREAPDSLFAVRRHLWGSHGNSTFPEFLHNMDYFKFHNMRPPFTYATLIRWAILEAPEKQRTLNEIYHWFTRMFAFFRNHPATWKNAIRHNLSLHKCFVRVESEKGAVWTVDELEFRKKRSQRPSRCSNPTPGP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | NPRPGKPSAPSLALG CCCCCCCCCCCCCCC | 57.19 | 22210691 | |
19 | Phosphorylation | PSLALGPSPGASPSW CCCCCCCCCCCCCHH | 33.88 | 22210691 | |
23 | Phosphorylation | LGPSPGASPSWRAAP CCCCCCCCCHHHCCC | 25.94 | 22210691 | |
25 | Phosphorylation | PSPGASPSWRAAPKA CCCCCCCHHHCCCCH | 27.05 | 26091039 | |
31 | Acetylation | PSWRAAPKASDLLGA CHHHCCCCHHHHCCC | 56.66 | 22312127 | |
33 | Phosphorylation | WRAAPKASDLLGARG HHCCCCHHHHCCCCC | 34.61 | - | |
44 | Phosphorylation | GARGPGGTFQGRDLR CCCCCCCCCCCCCCC | 20.78 | - | |
107 | Phosphorylation | PHFMHQLSTVDAHAR CCHHHHHHHCCHHCC | 21.58 | 22210691 | |
115 | Phosphorylation | TVDAHARTPVLQVHP HCCHHCCCCEEEEEC | 20.66 | 22210691 | |
138 | Phosphorylation | LTPPTTATGVFSLKA ECCCCCCCEEEEEEE | 31.61 | 22210691 | |
142 | Phosphorylation | TTATGVFSLKARPGL CCCCEEEEEEECCCC | 26.93 | - | |
179 | Acetylation | PNPSAPRKDSTLSAV CCCCCCCCCCCCCCC | 55.78 | 63828001 | |
227 | Acetylation | ADHLLDEKGRAQCLL HHHHCCHHHHHHHHH | 54.05 | 63828003 | |
250 | Acetylation | EQQLVLEKEKLSAMQ HHHHHHCHHHHHHHH | 56.86 | 63827999 | |
252 | Acetylation | QLVLEKEKLSAMQAH HHHHCHHHHHHHHHH | 59.83 | 63828005 | |
263 | Acetylation | MQAHLAGKMALTKAS HHHHHHHHHHHHHHH | 18.52 | 22312127 | |
268 | Acetylation | AGKMALTKASSVASS HHHHHHHHHHHHCCC | 47.31 | 22312127 | |
270 | Phosphorylation | KMALTKASSVASSDK HHHHHHHHHHCCCCC | 27.23 | - | |
274 | Phosphorylation | TKASSVASSDKGSCC HHHHHHCCCCCCCEE | 36.59 | - | |
275 | Phosphorylation | KASSVASSDKGSCCI HHHHHCCCCCCCEEE | 33.34 | - | |
296 | Phosphorylation | GPVVPAWSGPREAPD CCEECCCCCCCCCCC | 40.81 | 24667141 | |
342 | Phosphorylation | NMRPPFTYATLIRWA CCCCCCHHHHHHHHH | 9.66 | - | |
356 | Ubiquitination | AILEAPEKQRTLNEI HHHHCHHHHCHHHHH | 43.98 | - | |
393 | Ubiquitination | RHNLSLHKCFVRVES HHHCEEEEEEEEEEE | 34.36 | - | |
418 | Phosphorylation | LEFRKKRSQRPSRCS HHHHHHHHCCCCCCC | 39.15 | 22678915 | |
422 | Phosphorylation | KKRSQRPSRCSNPTP HHHHCCCCCCCCCCC | 48.37 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
19 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
270 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
274 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
342 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
422 | S | Phosphorylation | Kinase | PIM1 | P11309 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | STUB1 | Q9UNE7 | PMID:23973223 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOXP3_HUMAN !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...